U.S. markets close in 4 hours 55 minutes

Valneva SE (VALN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
10.84+0.27 (+2.55%)
As of 10:42AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Gravestone (Bullish)

Gravestone (Bullish)

Previous Close10.57
Bid10.57 x 900
Ask10.84 x 900
Day's Range10.58 - 10.84
52 Week Range9.77 - 40.70
Avg. Volume5,752
Market Cap761.861M
Beta (5Y Monthly)1.01
PE Ratio (TTM)6.34
EPS (TTM)1.71
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.34
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
7% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VALN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Valneva SE
    Daily – Vickers Top Buyers & Sellers for 11/22/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    4 months agoArgus Research
View more
  • GlobeNewswire

    VALNEVA - Declaration of shares and voting rights - February 28, 2023

    VALNEVA Declaration of shares and voting rightsFebruary 28, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: March 6, 2023 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the changeDate on which this change wa

  • Benzinga

    Valneva Shares Updated Data From Now Shelved COVID-19 Vaccine Development Program

    As previously announced, Valneva SE (NASDAQ: VALN) said it would not invest in further COVID-19 vaccine development, VLA2001, without a new partnership. However, it is completing the remaining clinical studies and submissions. Last week, the Committee for Medicinal Products for Human Use of the European Medicines Agency backed VLA2001 approval in adults as a booster dose after at least seven months following primary vaccination with VLA2001 (homologous booster dose) or with an adenoviral vector

  • GlobeNewswire

    Valneva Provides Clinical and Regulatory Updates for its COVID-19 Vaccine VLA2001

    Saint-Herblain (France), March 2, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced additional data from remaining clinical studies and an update on regulatory submissions for its inactivated COVID-19 vaccine, VLA2001. As previously announced, Valneva will not invest in further development of the vaccine, in the absence of a new partnership1. It is, however, completing remaining clinical studies and submissions as agreed with regulators. On Febru